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NATURE | VOL 404 | 23 MARCH 2000 | www.nature.com genotypes: (1) elav±GAL4/+; UAS±wild-type a-synuclein/+; (2) UAS±A30P a-synuclein/elav±GAL4; and (3) UAS±A53T a-synuclein/elav±GAL4. Sections were stained with haematoxylin and eosin. Time points monitored were 1, 10, 30 and 60 days. In addition, serial 1-mm sections of glutaraldehyde-®xed heads from¯ies of the same genotypes prepared at 1, 30 and 60 days were stained with toluidine blue to highlight degenerating cells. No evidence of excess neurodegeneration was detected using either technique.
To evaluate dopaminergic cells of the dorsomedial cluster by tyrosine hydroxylase immunostaining, serial 4-mm sections were cut to include the entire brain. Immunopositive cells at the level of the giant interneuron commissure, posterior to the fan-shaped body, were counted in well oriented frontal sections at 1, 10, 30 and 60 days. At 1 day all control and experimental sections contained four or ®ve cells in the delineated region. At 30 and 60 days all controls showed four or ®ve cells. At 30 and 60 days all a-synucleinexpressing animals (a-synuclein, elav±GAL4 and a-synuclein, Ddc±GAL4 transheterozygotes) showed 0 or 1 tyrosine-hydroxylase-positive cell in the de®ned region. Tyrosinehydroxylase-positive cells outside the dorsomedial cluster were present, and served as internal controls for the immunostaining procedure. At least four, and usually between six and ten brains were examined for wild-type a-synuclein and each mutant a-synuclein. Controls included young and aged¯ies of the genotypes elav±GAL4/+ and Ddc±GAL4/+. We evaluated expression of a-synuclein and b-galactosidase on similar serial section preparations. Quanti®cation was simpli®ed in these experiments because no clear cellbody-associated a-synuclein or b-galactosidase immunoreactivity was observed in the aged a-synuclein transgenic¯ies at the times reported.
For histological examination of retinas, heads were ®xed in glutaraldehyde and embedded in epon. Tangential retinal sections were prepared at a thickness of 1 mm and stained with toluidine blue (Fig 4) .
Standard electron microscopy was performed on brains from 25-day-old experimental (UAS±A30P a-synuclein/elav±GAL4) and control (elav±GAL4/+)¯ies. For immunoelectron microscopy, pre-embedding immunohistochemistry with an Hrp-congugated secondary antibody was performed on 60-day adult brains from experimental (UAS± A30P a-synuclein/elav±GAL4) and control (elav±GAL4/+)¯ies ®xed in 4% paraformaldehyde with 0.5% glutaraldehyde. Tissue was post-®xed in osmium and embedded in epon. Unstained ultrathin sections and ultrathin sections stained with uranyl acetate and lead citrate were examined.
Climbing assay
The climbing assay was performed as described 19, 20 . Forty¯ies were placed in a plastic vial, and gently tapped to the bottom of the vial. The number of¯ies at the top of the vial was counted after 18 s of climbing. Twenty trials were performed for each time point. The data shown represent results from a cohort of¯ies tested serially over 55 days. The experiment was repeated three times, with independently derived transgenic lines. Similar results were obtained from each experiment. The experiment was carried out under red light (Kodak Safelight Filter 1A). Control¯ies were of the genotype elav±GAL4/+. Experimental animals were of the following genotypes: (1) elav±GAL4/+; UAS±wild-type a-synuclein/+; (2) UAS±A30P a-synuclein/elav±GAL4; and (3) UAS±A53T a-synuclein/elav±GAL4. with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion 2 , whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy 3 , which are presumptive precursors of gastric cancer 4 . Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are in near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA±protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-in¯ammatory cytokine 5 and a powerful inhibitor of gastric acid secretion 6, 7 . Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.
H. pylori infects half of the world's population and has been implicated in the pathogenesis of gastric cancer 1 , the second-most common malignancy worldwide 8 . The mechanism of H. pyloriinduced carcinogenesis is not clear. The infection almost always causes in¯ammation of the gastric mucosa, the distribution and severity of which varies widely and affects the clinical outcome. Gastritis that is con®ned to the antral region is associated with excessive acid production and a high risk of duodenal ulcer disease 2 . In contrast, gastritis involving the acid-secreting corpus region leads to hypochlorhydria, progressive gastric atrophy 3 and an increased risk of gastric cancer 4, 9 . These pre-cancerous changes are unfavourable to H. pylori growth and some gastric cancers arise long after the infection has disappeared. Duodenal ulceration and gastric cancer seem to be mutually exclusive outcomes of H. pylori infection that cannot be explained by differences in bacterial virulence factors alone, as virulent strains seem to be equally associated with both conditions 10, 11 . An alternative explanation is that host genetic factors (in conjunction with bacterial and/or environmental factors) determine the immune and in¯ammatory responses to H. pylori infection. A critical factor in H. pylori-induced gastric carcinogenesis is gastric acid secretion, which both in¯uences and is in¯uenced by H. pylori-induced gastritis. If in¯ammation of the corpus mucosa is severe, acid secretion is inhibited and eventually lost through the destruction of gastric glands 3 . Furthermore, pharmacological inhibition of acid secretion leads to the re-distribution of H. pyloriinduced gastritis with a reduced intensity of antral in¯ammation and an increased intensity in the corpus, and may progress to gastric atrophy in the long term 12 . Endogenous factors that suppress acid secretion could also contribute to corpus gastritis and atrophy.
The interleukin-1 (IL-1) gene cluster on chromosome 2q contains 3 related genes within a 430-kilobase (kb) region, IL-1A, IL-1B and IL-1RN, which encode the pro-in¯ammatory cytokines IL-1a and IL-1b as well as their endogenous receptor antagonist IL-1ra respectively 5 . IL-1b is upregulated in the presence of H. pylori and is important in initiating and amplifying the in¯ammatory response to this infection 13±15 . IL-1b is also a potent inhibitor of gastric acid secretion 6, 7 ; on a molar basis it is estimated to be 100-fold more potent than proton pump inhibitors and 6,000-fold more potent than H 2 antagonists 16 . Three diallelic polymorphisms in IL-1B have been reported, all representing C±T base transitions, at positions -511, -31 and +3954 base pairs (bp) from the transcriptional start site 17 . There are con¯icting data regarding the functional effects of these polymorphisms on IL-1b production 18, 19 . The IL-1RN gene has a penta-allelic 86-bp tandem repeat (VNTR) in intron 2, of which the less common allele 2 (IL-1RN*2) is associated with a wide range of chronic in¯ammatory and autoimmune conditions 17 . IL-1RN*2 is associated with enhanced IL-1b production in vitro 19 , but data regarding its effects on IL-1ra production are contradictory 20±22 .
To determine whether these polymorphisms are important with respect to the different outcomes of H. pylori infections, we studied their effects on gastric physiology in healthy subjects. We had previously shown that a cohort of 149 ®rst-degree relatives of gastric cancer patients from the West of Scotland had a high prevalence of hypochlorhydria (de®ned as a pentagastrin-stimulated peak acid output of less than 15 mmol h -1 ) in association with H. pylori infection 23 . Of the 103 (69%) gastric cancer relatives (GCR) infected with the H. pylori, 45 had hypochlorhydria and gastric atrophy and 58 had normal or high acid secretion. One hundred unselected newborns from the West of Scotland were available as population controls. We also had available a case-control study of gastric cancer, based on a population from Warsaw, Poland, in which there were 393 gastric cancer cases and 430 controls with DNA samples 24 . We were thus able to determine whether genotypes that modify IL-1b are associated with low acid secretion and gastric atrophy, and whether these same genotypes increase the risk of gastric cancer. These studies were reviewed and approved by the Institutional Review Boards and Ethics Committees of the US National Cancer Institute, the University of Glasgow Hospitals NHS Trust, and the M. Sklodowska-Curie Memorial Cancer Centre (Warsaw).
In both the Scottish and Polish control populations, the alleles at the individual loci of IL-1B and IL-1RN were in Hardy±Weinberg equilibrium, with non-signi®cant x 2 values. There was marked linkage disequilibrium among the loci within the gene cluster (see also ref. 25) . Linkage disequilibrium between IL-1B 2 31 and IL-1B 2 511 was almost total, with 99.5% of the inferred haplotypes (IL-1B 2 31=IL-1B 2 511) in the combined control groups consisting of either T±T or C±C (Table 1 ). There was also strong linkage disequilibrium (D9 < 0:5) between IL-1B 2 31 and IL-1RN in both populations. However, the two groups differed with respect to linkage disequilibrium between IL-1B 2 31 and IL-1B 3954, which was strong in the Scottish population controls but relatively weak (D9 2 0:16) in the Polish controls. There was no signi®cant linkage disequilibrium between IL-1B 3954 and IL-1RN in either control group.
There were no signi®cant differences in genotype frequency for any IL-1 marker between the GCR and controls or between the total H. pylori-infected and uninfected GCR ( Table 2) . Nevertheless, among the infected GCR, those with low acid secretion had a signi®cantly higher frequency of the pro-in¯ammatory IL-1RN*2 allele and the T±T haplotype of IL-1B 2 31 and IL-1B 2 511 (IL-1B 2 31T=1L-1B 2 511T), as compared with the GCR with normal or high acid secretion. Carriers of the T allele of IL-1B 2 31 (IL-1B 2 31T) had an age-adjusted odds ratio of 9.1 (95% con®dence interval (CI), 2.2±37), and there was little difference between the homozygous and heterozygous carriers ( Table 2) . IL-1RN*2 homozygotes (IL-1RN*2/*2) were also at increased risk of hypochlorhydria, although risk among the IL-1RN*2 heterozygotes was not signi®cantly increased ( Table 2 ). In a logistic regression model including both factors, the estimated age-adjusted odds ratios for IL-1B 2 31T and IL-1RN*2/*2 were 7.5 (95% CI, 1.8± 31) and 2.1 (95% CI, 0.7±6.3), respectively. The IL-1B 3954 genotype was not associated with the risk of hypochlorhydria.
There were similar associations between these alleles and the risk of gastric cancer. Carriers of IL-1B 2 31T had an increased gastric cancer risk at an odds ratio of 1.9 (95% CI, 1.5±2.6), with no signi®cant difference between homozygotes and heterozygotes (Table 3) . Moreover, IL-1RN*2 was associated with an increased risk in homozygotes but not in heterozygotes (Table 3 ). In a logistic regression model including both of these genotypes, the estimated odds ratios for IL-1B 2 31T and IL-1RN*2/*2 were 1.6 (95% CI, 1.2±2.2) and 2.9 (95% CI, 1.9±4.4), respectively. IL-1B 3954T homozygotes seemed to be protected against gastric cancer, although the effect did not reach statistical signi®cance ( Table 3 ).
The estimated effects of IL-1B 2 31T and IL-1RN*2/*2 were similar in subgroups of gastric cancer cases de®ned by age, sex, histological type and anatomical site (data not shown). Furthermore, adjustment for other reported risk factors for gastric cancer, including tobacco and alcohol use, ABO blood group and family history of gastric cancer, did not substantially alter the estimates (data not shown).
The IL-1B 2 31T=IL-1RN*2 haplotype imparted a greatly increased risk of gastric cancer, as compared with having no copy of IL-1B 2 31T and at least one copy of the other IL-1RN alleles. Twenty-two per cent of cases (compared with eight per cent of controls) had this haplotype, either in its homozygous form or with IL-1B 2 31C=IL-1RN*2, with an odds ratio of 4.4 (95% CI, 2.8±6.9). In the absence of IL-1B 2 31T, homozygous IL-1RN*2 was associated with a similarly elevated odds ratio of 5.3 (95% CI, 1.9±14), although this genotype combination was uncommon because of linkage disequilibrium between the two loci. In contrast, the odds ratio for IL-1B 2 31T with no more than one copy of IL-1RN*2 was only 1.7 (95% CI, 1.2±2.3). Nonetheless, because its effect is observed in both homozygotes and heterozygotes, the IL-1B 2 31T allele accounts for a greater proportion of excess gastric cancer cases than the IL-1RN*2 allele, despite their comparable frequencies. The fraction of gastric cancer in the population that is attributable to IL-1B 2 31T is estimated to be 31%, compared with 18% for IL-1RN*2. Their combined population attributable fraction is estimated to be 38%, which represents the fraction of gastric cancer cases that are caused by these IL-1 alleles. The IL-1B 2 31 polymorphism involves a TATA sequence in the IL-1B promoter. To investigate the effect of IL-1B 2 31 variants on the induction of IL-1b, we used electrophoretic mobility-shift analysis to assess their DNA-binding activity in vitro. Synthetic allele-speci®c oligonucleotides representing the polymorphic IL-1B 2 31 sites were incubated with nuclear protein extracts from non-stimulated human monocytes and monocytes activated by lipopolysaccharide (LPS). LPS stimulation induced a ®vefold increase in DNA binding (complex 1) on the IL-1B 2 31T oligonucleotide (Fig. 1, lanes 1 and 2) . In contrast, LPS failed to induce complex 1 formation on the IL-1B 2 31C oligonucleotide (Fig. 1,  lanes 5 and 6) . Furthermore, complex 1 formation on radiolabelled IL-1B 2 31T was speci®cally blocked by competition with the unlabelled IL-1B 2 31T, but not the IL-1B 2 31C, oligonucleotide (Fig. 1, lanes 3 and 4) . These results indicate that one or more proteins (presumably transcription factors) in complex 1 may be unable to interact with the C-bearing IL-1B 2 31 allele to form the transcription initiation complex. In parallel experiments assessing allele-speci®c oligonucleotides for IL-1B 2 511, there were no differences in binding activity (data not shown), indicating that the effect of IL-1B 2 511 may be mediated by linkage disequilibrium with the TATA box polymorphism. On the basis of these results and previously published functional data for IL-1RN, hypochlorhydria and gastric cancer may be associated with alleles of IL-1B 2 31 and IL-1RN that enhance IL-1b production.
Here we demonstrate that pro-in¯ammatory genotypes of the IL-1 loci (IL-1B 2 31T and IL-1RN*2/*2) increase both the likelihood of a chronic hypochlorhydric response to H. pylori infection and the risk of gastric cancer, presumably by altering IL-1b levels in the stomach. While the pro-in¯ammatory effects of high IL-1b concentrations may facilitate the clearance of H. pylori from the gastric mucosa, the concomitant inhibition of acid secretion allows the spread of H. pylori-induced in¯ammation from the antrum to the corpus. This functional inhibition is initially reversible but the progressive destruction of parietal cells eventually leads to irreversible hypochlorhydria. A decreased¯ow of gastric secretions may therefore heighten mucosal damage by allowing the accumulation of bacterial toxins and by-products of in¯ammation that would normally be diluted and¯ushed out. The reactive oxygen and nitrogen oxide species that are derived from in¯ammation are known mutagens, while hypochlorhydria permits superinfection by other bacteria that enhance the production of highly carcinogenic N-nitroso compounds 26 .
H. pylori-induced hypochlorhydria also markedly reduces the levels of vitamin C in gastric juice 27 , further facilitating the forma-tion of N-nitroso compounds. The opportunities for DNA damage caused by this cascade of genotoxic factors are ampli®ed by the increased rate of cell turnover in in¯amed mucosa. Therefore, genotypes that enhance IL-1b production may favour the initiation of a set of responses to H. pylori that result in hypochlorhydria, corpus atrophy and an increased risk of gastric cancer.
Our ®ndings complement the most widely accepted multi-stage model of gastric carcinogenesis 4 , and provide insights into the etiological role of H. pylori. We have shown at least two susceptibility loci in the IL-1 gene cluster for gastric cancer and its precursors. The effects of these loci in¯uence an early stage of the disease process and require the presence of H. pylori infection. Progression towards cancer is probably in¯uenced by other components of the host genetic constitution acting epistatically, as well as by dietary and other factors in the environment. IL-1B 2 31T=IL-1RN*2 constitutes a pro-in¯ammatory haplotype that is in strong linkage disequilibrium, at least in Caucasian populations. We speculate that this linkage disequilibrium re¯ects past selective pressures for or against enhancement of the IL-1b response to environmental challenges. Whereas pro-in¯ammatory genotypes may be advantageous for the host response to some infections, the vigorous IL-1b production associated with H. pylori gastric infection may exacerbate mucosal damage and increase the risk of eventual neoplasia. For TaqMan assays, primers (Operon Technologies Inc.) and probes (PE Applied Biosystems) were designed using Primer Express software (PE Applied Biosystems). Probes for the T or C allele were 59-labelled with either FAM (6-carboxy¯uoresceine) or VIC¯uorogenic dyes, and 39-labelled with TAMRA (6-carboxytetramethylrhodamine) quencher. PCR ampli®cation was performed in a volume of 25 ml containing 50 ng genomic DNA, 1´TaqMan Universal Master Mix (PE Applied Biosystems), 200 nM for each probe and 900 nM for primers. Cycling conditions were 50 8C for 2 min, 95 8C for 10 min, then 40 cycles of 95 8C for 15 s and 62 8C for 1 min, as recommended by the manufacturer. Thermal cycling of optical plates was performed in GeneAmp PCR System 9700 and endpoint analysis was performed in the ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems). Sequences of primers and probes for IL-1B TaqMan assays are available from the authors.
For IL-1RN, genomic DNA was ampli®ed using PCR under the conditions described above for IL-1B, using forward primer 59-CCCCTCAGCAACACTCC-39 and reverse primer 59-GGTCAGAAGGGCAGAGA-39. The PCR products were separated by electrophoresis on 2% agarose gels and stained with ethidium bromide. Alleles were sized relative to a 1-kb DNA ladder and coded conventionally as follows: allele 1 4 repeats, allele 2 2 repeats, allele 3 5 repeats, allele 4 3 repeats, allele 5 6 repeats; the rarer alleles 3, 4 and 5 were grouped in the statistical analysis.
A total of 93% (366/393) of the gastric cancer cases, 99% (429/430) of their population controls, and all GCR subjects and their newborn population controls were successfully genotyped for all four loci.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from freshly isolated human monocytes as described 29 Complementary strands were annealed by combining 2 mg of each oligonucleotide and 6 ml of 10´annealing buffer (500 mM Tris, 100 mM MgCl 2 and 50 mM dithiothreitol) in a 60-ml reaction, placing in a boiling water bath for 5 min and allowing to cool to room temperature. The DNA±protein binding reaction was conducted in a 20-ml volume containing 7 mg of nuclear protein extract, 1 mg poly (dI±dC) (Sigma), 4 ml of 5´binding Productive interaction of a T lymphocyte with an antigen-presenting cell results in the clustering of the T-cell antigen receptor (TCR) and the recruitment of a large signalling complex to the site of cell±cell contact 1,2 . Subsequent signal transduction resulting in cytokine gene expression requires the activation of one or more of the multiple isoenzymes of serine/threonine-speci®c protein kinase C (PKC) 3 . Among the several PKC isoenzymes expressed in T cells, PKC-u is unique in being rapidly recruited to the site of TCR clustering 4 . Here we show that PKC-u is essential for TCRmediated T-cell activation, but is dispensable during TCR-dependent thymocyte development. TCR-initiated NF-kB activation was absent from PKC-v -/mature T lymphocytes, but was intact in thymocytes. Activation of NF-kB by tumour-necrosis factor a and interleukin-1 was unaffected in the mutant mice. Although studies in T-cell lines had suggested that PKC-u regulates activation of the JNK signalling pathway 5,6 , induction of JNK was normal in T cells from mutant mice. These results indicate that PKC-u functions in a unique pathway that links the TCR signalling complex to the activation of NF-kB in mature T lymphocytes. We inactivated the gene encoding PKC-u by homologous recombination in embryonic stem cells by replacing the exon encoding the ATP-binding site of the kinase domain (amino-acid residues 396± 451) with the neomycin resistance gene. Homozygous mutant mice seemed normal and were fertile. Immunoblot analysis with antibodies directed against sequences outside the deleted coding region of PKC-u failed to detect any protein product, even of smaller than normal size, in thymocytes or T cells from the mutant animals (data not shown). Flow cytometric analyses of cells from thymus, spleen and lymph nodes of the mutant mice were indistinguishable from
